Delivery Order SPE2DB22D1017-SPE2DB24FG3PE

Award Date 8/20/24
Potential Completion Date 8/21/24
Potential Value $6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,966.62, is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of February 12, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of ELIQUIS 5 MG TABLET 60S. The contract is valued at $2,080.52 and has an ultimate completion date of August 23, 2024. The contract is a firm-fixed-price type and does not have a set-aside designation. As a significant supplier of pharmaceutical and medical products to the U.S. federal government, AmerisourceBergen holds...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,060.94 Firm Fixed Price Delivery Order is for the supply of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of September 20, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,843.31, is for the delivery of the prescription drug ELIQUIS 5 MG TABLET 60S. It is a firm fixed price contract with an ultimate completion date of October 31, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,764.94 fixed-price delivery order is for the supply of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The order has an ultimate completion date of August 20, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to various government agencies. The company holds several Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,843.02 firm fixed-price contract is for the delivery of 4565021792 tablets of the medication ELIQUIS 5 MG. The contract has an ultimate completion date of June 28, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of ELIQUIS 5 MG TABLET 60S. The contract has a ceiling value of $55,878.68 and a completion date of September 13, 2024. As one of the largest pharmaceutical distributors in the U.S., Amerisourcebergen has extensive experience providing a wide range of prescription medications, medical supplies, and equipment to various federal agencies and healthcare programs. This delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,965.60, is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of February 7, 2025 and is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen Drug Corp is a for-profit organization registered in...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,004.45, is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The contract has a completion date of June 18, 2024 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for $25,732.00. The order is for 4566718868 ELIQUIS 5 MG TABLET 60S, a prescription pharmaceutical product. The contract has a firm fixed-price pricing type and a period of performance through December 16, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division to provide a comprehensive...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FG3PE
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation in the amount of $5,955.23 for the supply of ELIQUIS 5 MG TABLET 60S pharmaceutical products. The contract has an ultimate completion date of August 21, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as well as multiple Indefinite Delivery Contracts (IDCs) by DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued at up to $999,999,999 and $750,000 respectively, to provide a comprehensive range of medical commodities and prescription drugs to support various government healthcare programs and facilities. This contract is not designated as a set-aside.

Generated 11/19/24, 9:29 AM